Products & Divisions

SkinBioTherapeutics translates evidence-based science into commercial products, intellectual property for out-licensing, that address skin health from inside out and outside in, and services.
Our portfolio spans topical products, oral food supplements, intellectual property and in-house manufacturing. Each division operates in a distinct area of skin health, and together they form an integrated group capable of moving from scientific discovery to commercial product within the same organisation.
Our approach reflects a core biological insight: skin health is shaped by what happens both inside the body and on its surface. Our oral products address the gut-skin axis, while our topical products address the skin’s surface and barrier function. Our services division focuses specifically on topical development.
We do not conduct early-stage discovery in isolation. We identify promising science through collaboration with world-class universities, research institutions, and commercial partners. Those relationships are central to how we build and scale our portfolio.
Bio-Tech Solutions, our in-house manufacturing division, is core to our product development strategy.

AxisBiotix

AxisBiotix is an oral food supplement designed to support the gut microbiome and improve skin health from within. There are currently two products on the market: SkinCalm and SkinClear.

AxisBiotix works through the gut-skin axis: the two-way biological relationship between gut health and skin function. When the gut microbiome is imbalanced, it can contribute to skin inflammation and sensitivity to blemishes.

Following the BRIGHT Study and Project Mirror, over two-thirds of participants who completed the studies reported significant improvements in their skin condition within eight weeks.

AxisBiotix products are available directly to consumers and on Amazon and are stocked in selected Superdrug stores across the UK.

AxisBiotix

Image

Dermatonics

The Professional Range

The professional range is prescribed by GPs, podiatrists, dermatologists, and nurses. Products are clinically formulated to address conditions including anhydrotic and fissured skin, calluses, hyperkeratosis, and dry or compromised skin in at-risk patient groups including those with diabetes. Dermatonics products are listed on the UK Drug Tariff.

A clinical review published in the Diabetic Foot Journal in March 2020 for Once Heel Balm found that up to 96% of high-risk NHS patients had their callus successfully treated within 14 days.

Image

 

The Retail Range

The cosmetic range, Green & Gold, is designed for everyday skin health and is available directly to
consumers.
Formulations combine urea with natural ingredients such as manuka honey, colloidal oatmeal to deliver targeted
solutions for dry, rough, and irritated skin on the feet, hand and body.
Products are available directly to consumers online via Dermatonics’ ecommerce store and Amazon and are stocked
in Boots and Superdrug stores across the UK.

Dermatonics

Image

Bio-Tech Solutions

Bio-Tech Solutions Limited (BTS) specialises in the contract manufacturing and packaging of a range of health, hygiene, and personal care products.

BTS supports a range of external customers in both human and animal health sectors, from the NHS and private institutions to partnerships with medical wholesalers and veterinary product distributors. Its services include labelling, R&D product support, and full-service contract manufacturing.

Through its contract manufacturing activities, BTS creates incremental revenue streams and supports the group’s manufacturing capacity.

Bio-Tech Solutions

Image